JP2022513215A5 - - Google Patents

Info

Publication number
JP2022513215A5
JP2022513215A5 JP2021533641A JP2021533641A JP2022513215A5 JP 2022513215 A5 JP2022513215 A5 JP 2022513215A5 JP 2021533641 A JP2021533641 A JP 2021533641A JP 2021533641 A JP2021533641 A JP 2021533641A JP 2022513215 A5 JP2022513215 A5 JP 2022513215A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
group
pharmaceutically acceptable
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021533641A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513215A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/066414 external-priority patent/WO2020124060A1/en
Publication of JP2022513215A publication Critical patent/JP2022513215A/ja
Publication of JP2022513215A5 publication Critical patent/JP2022513215A5/ja
Pending legal-status Critical Current

Links

JP2021533641A 2018-12-14 2019-12-14 C-met阻害剤としての有機リン置換化合物およびその治療用途 Pending JP2022513215A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862779960P 2018-12-14 2018-12-14
US62/779,960 2018-12-14
PCT/US2019/066414 WO2020124060A1 (en) 2018-12-14 2019-12-14 Organophosphorus-substituted compounds as c-met inhibitors and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
JP2022513215A JP2022513215A (ja) 2022-02-07
JP2022513215A5 true JP2022513215A5 (https=) 2022-11-24

Family

ID=71077551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021533641A Pending JP2022513215A (ja) 2018-12-14 2019-12-14 C-met阻害剤としての有機リン置換化合物およびその治療用途

Country Status (15)

Country Link
US (1) US12258365B2 (https=)
EP (1) EP3893872B1 (https=)
JP (1) JP2022513215A (https=)
KR (1) KR20210111779A (https=)
CN (1) CN113412112B (https=)
AU (1) AU2019395282A1 (https=)
BR (1) BR112021011547A2 (https=)
CA (1) CA3122575A1 (https=)
EA (1) EA202191541A1 (https=)
IL (1) IL283589A (https=)
MX (1) MX2021006982A (https=)
SG (1) SG11202105872RA (https=)
TW (1) TW202039500A (https=)
WO (1) WO2020124060A1 (https=)
ZA (1) ZA202104000B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116969955B (zh) * 2023-09-25 2023-12-19 中国药科大学 一种[1,2,4]三唑[4,3-b]哒嗪类化合物及其制法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20170103T1 (hr) 2005-12-21 2017-03-24 Janssen Pharmaceutica N.V. Triazolopiridazini kao modulatori tirozin kinaze
NL2000613C2 (nl) * 2006-05-11 2007-11-20 Pfizer Prod Inc Triazoolpyrazinederivaten.
US20110039856A1 (en) * 2007-11-29 2011-02-17 Pfizer Inc. Polymorphs of a c-met/hgfr inhibitor
UY32049A (es) 2008-08-14 2010-03-26 Takeda Pharmaceutical Inhibidores de cmet
EA030141B1 (ru) 2009-12-31 2018-06-29 Хатчисон Медифарма Лимитед Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
ES2598530T3 (es) 2010-07-14 2017-01-27 Betta Pharmaceuticals Co., Ltd. Nuevos derivados heterocíclicos condensados útiles como inhibidores de la tirosina quinasa c-Met
TWI520962B (zh) * 2012-06-29 2016-02-11 As the c-Met tyrosine kinase inhibitors novel fused pyridine derivatives
CN103122000B (zh) * 2012-09-03 2013-12-25 中美冠科生物技术(太仓)有限公司 用作抗肿瘤药物的高选择性的c-Met激酶抑制剂
ES2877799T3 (es) * 2015-12-31 2021-11-17 Shanghai Pharmaceuticals Holding Co Ltd Sal de derivado de quinolina, formas polimórficas de la misma, métodos de preparación de la misma, composición y aplicaciones

Similar Documents

Publication Publication Date Title
JP2024543967A5 (https=)
KR102796209B1 (ko) 키나아제 억제제로서의 시클릭 이미노피리미딘 유도체
CN114430740A (zh) Egfr抑制剂、组合物及其制备方法
IL291099B2 (en) Aminothiazole compounds as c-kit inhibitors
HRP20230472T1 (hr) Novi derivati hidroksikiseline, postupak njihove priprave i farmaceutski sastavi koji ih sadrže
ES2911040T3 (es) Nuevos derivados de heteroaril amida como inhibidores selectivos de histona deacetilasa 1 y 2 (HDAC1/2)
JP2013539795A5 (https=)
JP2009511490A5 (https=)
JP2014506599A5 (https=)
NZ259114A (en) Pyrazolopyrimidines and pharmaceutical compositions thereof
JP2021504317A (ja) ハロアリルアミン類のssao/vap−1阻害剤とその用途
JP2015524448A (ja) アルキニルへテロ芳香環化合物及びその応用
JP2014524441A5 (https=)
KR102493943B1 (ko) 포유류 티로신 키나제 ROR1 활성의 저해제로서 유용한 2-페닐-3H-이미다조[4,5-b]피리딘 유도체
AU2016368257B2 (en) Five-membered heterocyclic amides wnt pathway inhibitor
JP2014520108A5 (https=)
JP2022526220A5 (https=)
JP2023534528A5 (https=)
BR112020007632A2 (pt) composto, composição farmacêutica, método para inibir um dentre ou tanto ehmt1 quanto ehmt2, método para prevenir ou tratar um distúrbio sanguíneo, método para prevenir ou tratar um câncer e uso do composto
JP2024511389A5 (https=)
CN112313207A (zh) 一种氰基取代吡啶及氰基取代嘧啶类化合物、制备方法及其应用
JP2022513215A5 (https=)
JP2005504790A5 (https=)
EP3277676A1 (en) Substituted quinazoline derivatives as dna methyltransferase inhibitors
EP2768809A1 (en) Pyridine- sulfoximines as tyrosine kinase inhibitors